Skip to content

MSI-High and dMMR in Colorectal Cancer: What the Result Means

CancerSnoop Test Guide
MSI-High and dMMR in Colorectal Cancer: What the Result Means

MSI-high and dMMR describe related changes found in a tumor. These results can help guide treatment discussions and may lead to testing for Lynch syndrome.

Test and result at a glance
Test Name Microsatellite instability (MSI) and mismatch repair (MMR) testing
Test Type Tumor biomarker testing
What It Measures Mismatch repair normally corrects certain DNA copying errors. MSI testing looks for changes in short repeated stretches of tumor DNA. An MMR immunohistochemistry test checks for the presence of specific repair proteins in tumor cells.
Used For Helping guide treatment decisions in relevant settings and identifying people who may need further evaluation for Lynch syndrome.
Cancer Types Colorectal cancer
Typical / Reference Range These are usually reported as categories. The report may say MSI-high or microsatellite stable, or describe MMR proteins as retained or lost.

Why the report uses two kinds of language

Mismatch repair is one of the ways cells correct errors when DNA is copied. An MSI test examines the tumor DNA for changes in repeated stretches of genetic material. Immunohistochemistry uses stains to check whether specific repair proteins are detectable in tumor cells. These methods look at related features. The report may describe a DNA result such as MSI-high or a protein result naming which proteins were lost. [1]

Does an abnormal tumor result mean I inherited Lynch syndrome?

An abnormal tumor result can lead to evaluation for Lynch syndrome, an inherited condition that increases the risk of colorectal and some other cancers. Changes in tumor cells can also occur without an inherited cause. Tumor testing and inherited genetic testing answer different questions. If the team recommends inherited testing, ask what sample it will use and who will interpret the result for you. [1] [3]

Why the team may order another tumor test

If the stain shows loss of MLH1 in a colorectal tumor, additional testing can help determine why the protein was lost. One example is checking for a change that switches off MLH1 in the tumor, called MLH1 promoter methylation. Your care team interprets that result alongside the original stain and your history when deciding whether further inherited-risk evaluation is appropriate. [1]

What it could mean for treatment

The tumor result can help guide treatment choices in relevant clinical settings. Ask whether the finding affects the current recommendation or is mainly useful for a later decision. The cancer stage and the setting in which a treatment is being considered matter. The words MSI-high or dMMR alone cannot tell you which treatment you will receive. [1] [2]

How to prepare for your appointment

Bring the full result if you have it. Ask which method was used, what the result means for treatment now and whether any follow-up testing is pending. If the clinician recommends genetic counseling, ask what the visit will cover and when it would be appropriate to discuss the result with family. [1] [3]

Which result should I share with my family?

Ask the genetics team whether your result comes from the tumor or from inherited testing. A tumor result alone does not establish an inherited risk for relatives. [1]

This guide is for general education. Your care team can interpret your individual results.

Sources and References

  1. Genetics of Colorectal Cancer (PDQ®)–Health Professional Version
  2. Tumor Marker Tests in Common Use
  3. Definition of Lynch syndrome
SHARE THIS EVIDENCE
WhatsApp ↗
Back To Top